Opacity in Covid vaccine trials, sales contracts could scupper global response
A new report released today by Transparency International and Toronto University shows that transparency in information relating to Covid-19 vaccine clinical trials and contracts is the exception rather than the rule. For Whose Benefit? is an in-depth study of the development and sale of the world’s top 20 Covid-19 vaccines, including those developed by AstraZeneca, Johnson & Johnson, Moderna, and Pfizer.
